Furthermore, recent studies have suggested that preoperative next-generation sequencing (NGS) of pancreatic cyst fluid (PCF) for KRAS and GNAS mutations is highly sensitive for IPMNs and specific for mucinous pancreatic cysts, making it possible to utilize the analysis of these mutations in cases where the diagnosis is unclear [5,13]. Here, KRAS is linked to Pancreatic cysts.